The global AI In Healthcare Market size is projected to be valued at USD 26.6 Billion in 2024 and reach USD 187.7 billion by ...

The FDA and NIH recently announced plans to phase out animal testing requirements for some therapies. While organoid and AI ...

From easing clinician workloads to enabling faster, smarter diagnoses, these practical AI tools are transforming healthcare ...

The increasing incidence of infectious and chronic illnesses is boosting the need for early and precise diagnosis, with AI playing a crucial role by ...

Lantern Pharma's Q1 2025 earnings reveal clinical progress, AI commercialization plans, and financial discipline.

Guest blog from Laura Foster, Associate Director for Technology and Innovation at techUK , as part of our ...

The annual analysis documented approvals of 18 new personalized medicines in 2024, important regulatory milestones and establishment of the Center fo ...

GE HealthCare (Nasdaq: GEHC) today announced the launch of its CleaRecon DL technology for enhancing CBCT imaging.

Stuart J. Schnitt, MD, discussed how AI enhances cancer diagnoses and the need for professional oversight, ethical clarity, and equitable adoption.

We recently published a list of the 10 Most Popular AI Stocks to Avoid Now. In this article, we are going to take a look at where Recursion Pharmaceuticals, Inc.

Healthcare employees have reportedly been uploading sensitive patient information to unauthorised websites and cloud services ...